Tnuva Prepares for 2027 IPO at $3.5 Billion Valuation
Translated & summarized from Calcalist by baba
Israeli food company Tnuva is preparing for a public offering in the second half of 2027, aiming for a valuation of approximately 13 billion shekels. The company has begun drafting a new prospectus and plans to meet with underwriters. This follows a previous IPO attempt halted in 2026. Tnuva's improved financial results and expansion into dietary supplements are driving the renewed effort.
The story in 6 lines · by baba
- Tnuva is preparing for a public offering in the second half of 2027.
- The company aims for a valuation of approximately 13 billion shekels ($3.5 billion) in the IPO.
- Tnuva has started drafting a new prospectus with the law firm Meitar.
- The IPO preparations involve its Chinese and kibbutz shareholders.
- The company recently launched a new line of dietary supplements.
- Tnuva's revenue has grown consistently, nearing 10 billion shekels.
Israeli food giant Tnuva is renewing preparations for a public offering, with the company beginning to draft a new prospectus in recent weeks for a potential IPO in the second half of 2027. The law firm Meitar is handling the prospectus preparation, and Tnuva plans to meet with leading underwriters soon. While the board has not formally decided, management has initiated the process with its Chinese and kibbutz shareholders.
The company, owned by China's Bright Food (76%) and the Kibbutz Movement's purchasing organizations (24%), aims for a valuation of approximately 13 billion shekels ($3.5 billion) in the offering. This is an increase from a previous target of around 10 billion shekels for a planned 2025 IPO. The higher valuation is attributed to improved company performance and the recent launch of a new line of dietary supplements.
In April 2026, Tnuva had halted its IPO process due to business environment changes and dairy market reforms. The company is now moving forward, with shareholders potentially selling some of their stakes. Bright Food acquired its controlling stake in Tnuva in 2015 for 8.6 billion shekels.
Recent strategic moves by Tnuva include a 600 million shekel investment plan, featuring a new logistics center in Netivot, relocating the Ma'adan poultry factory, and installing new milk processing machinery. The company also recently launched its HOLIS brand in the dietary supplement market, focusing on microbiome research and offering 11 products across nine categories.
Tnuva's revenue has grown consistently, nearing 10 billion shekels, partly due to increased food consumption during recent conflicts. Its EBITDA rose to approximately 1.22 billion shekels. The company processes about a billion liters of milk annually and also produces milk alternatives, frozen meats, and frozen vegetables under brands like Alter-Milk, Maadan, Adom Adom, and Sanfrost.
Mentioned
The same event, reported separately by each outlet. Open a few to compare what different newsrooms emphasize — and what they leave out.
Other 2